Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001104659-19-041303

10% owner acquired 464,285 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Section 32 Fund 2, LP 10% owner 2019-07-22 Conversion +464,285 464,285 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Section 32 Fund 2, LP 10% owner 2019-07-22 Conversion · Series B Preferred Stock −3,250,000 0 D: show line 2 in the form
Loading xslF345X03/a4.xml…